Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
IL-15 regulates memory CD8+ T cell O-glycan synthesis and affects trafficking
Jeffrey C. Nolz, John T. Harty
Jeffrey C. Nolz, John T. Harty
Published February 10, 2014
Citation Information: J Clin Invest. 2014;124(3):1013-1026. https://doi.org/10.1172/JCI72039.
View: Text | PDF
Research Article Immunology

IL-15 regulates memory CD8+ T cell O-glycan synthesis and affects trafficking

  • Text
  • PDF
Abstract

Memory and naive CD8+ T cells exhibit distinct trafficking patterns. Specifically, memory but not naive CD8+ T cells are recruited to inflamed tissues in an antigen-independent manner. However, the molecular mechanisms that regulate memory CD8+ T cell trafficking are largely unknown. Here, using murine models of infection and T cell transfer, we found that memory but not naive CD8+ T cells dynamically regulate expression of core 2 O-glycans, which interact with P- and E-selectins to modulate trafficking to inflamed tissues. Following infection, antigen-specific effector CD8+ T cells strongly expressed core 2 O-glycans, but this glycosylation pattern was lost by most memory CD8+ T cells. After unrelated infection or inflammatory challenge, memory CD8+ T cells synthesized core 2 O-glycans independently of antigen restimulation. The presence of core 2 O-glycans subsequently directed these cells to inflamed tissue. Memory and naive CD8+ T cells exhibited the opposite pattern of epigenetic modifications at the Gcnt1 locus, which encodes the enzyme that initiates core 2 O-glycan synthesis. The open chromatin configuration in memory CD8+ T cells permitted de novo generation of core 2 O-glycans in a TCR-independent, but IL-15–dependent, manner. Thus, IL-15 stimulation promotes antigen-experienced memory CD8+ T cells to generate core 2 O-glycans, which subsequently localize them to inflamed tissues. These findings suggest that CD8+ memory T cell trafficking potentially can be manipulated to improve host defense and immunotherapy.

Authors

Jeffrey C. Nolz, John T. Harty

×

Figure 9

IL-15 regulates expression of core 2 O-glycans and Gcnt1 in memory CD8+ T cells.

Options: View larger image (or click on image) Download as PowerPoint
IL-15 regulates expression of core 2 O-glycans and Gcnt1 in memory CD8+ ...
(A and B) Naive B6 mice were challenged intranasally with CpG, and IL-15 levels were measured in the (A) sera and (B) spleens. LOD, limit of detection. (C) Naive and memory P14 CD8+ T cells were purified and cultured in vitro for 3 days with the indicated concentrations of IL-15. Expression of core 2 O-linked glycosylated CD43 (1B11) was then determined. (D) Memory P14 CD8+ T cells were purified and cultured in vitro for 3 days in media alone (control) or with 50 ng/ml IL-15. The ability for the cells to bind to either P- or E-selectin was then determined using P- and E-selectin chimeric proteins. (E) Memory P14 CD8+ T cells were purified and cultured in vitro with 50 ng/ml IL-15 and the indicated concentrations of the STAT5 inhibitor N′-((4-Oxo-4H-chromen-3-yl)methylene)nicotinohydrazide for 3 days. Expression of core 2 O-linked glycosylated CD43 (1B11) was then determined. (F) Memory CD8+ T cells were purified and cultured in vitro for 3 days with the indicated concentrations of IL-15. Expression of Gcnt1 and glycosylation of PSGL-1 from whole cell extracts was then determined by immunoblot.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts